Clinical trial

Study of Continuous OSI-906 Dosing

NCT00514007

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-06-18

PhasePHASE1

Study timeline

Study start (actual)2007-06-18Date precision: day

Registry last updated2024-11-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Solid Tumorsunresolved

Interventions

OSI-906DRUG

Sponsors & collaborators

Astellas Pharma Inclead sponsor

Mapped research locations

NashvilleTennessee, United States1 GlasgowUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00514007 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.